Stability of norepinephrine infusions prepared in dextrose and normal saline solutions

Canadian Journal of Anesthesia

Volumn 55, Issue 3, 2008, Pages 163-167

  Tremblay, Maryse ^a   Lessard, Martin R ^a,b   Trépanier, Claude A ^a   Nicole, Pierre C ^a   Nadeau, Linda ^a   Turcotte, Gilles ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; NORADRENALIN; SODIUM CHLORIDE;

ANALYSIS OF VARIANCE; ARTICLE; DRUG DEGRADATION; DRUG STABILITY; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PH; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL ANALYSIS;

EID: 41349115925     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03016090     Document Type: Article

References (16)

1. Hollenberg SM, Ahrens TS, Annane D, et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med 2004; 32: 1928-48.
2. Ogle CW. Noradrenaline in the tropics. Br Med J 1968; 2: 490.
3. Hugues IE, Smith JA. The stability of noradrenaline in physiological saline solutions. J Pharm Pharmacol 1978; 30: 124-6.
4. West GB. The stability of noradrenaline solutions. J Pharm Pharmacol 1952; 4: 560-5.
5. Newton DW, Fung EY, Williams DA. Stability of five catecholamines and terbutaline sulfate in 5% dextrose injection in the absence and presence of aminophylline. Am J Hosp Pharm 1981; 38: 1314-9.
6. Allwood MC. The stability of four catecholamines in 5% glucose infusions. J Clin Pharm Ther 1991; 16: 337-40.
7. Peddicord TE, Olsen KM, ZumBrunnen TL, Warner DJ, Webb L. Stability of high-concentration dopamine hydrochloride, norepinephrine bitartrate, epinephrine hydrochloride and nitroglycerin in 5% dextrose injection. Am J Health Syst Pharm 1997; 54: 1417-9.
8. Stewart JT, Warren FW, King AD. Stability of ranitidine hydrochloride and seven medications. Am J Hosp Pharm 1994; 51: 1802-7.
9. Baumgartner TG, Knudsen AK, Dunn AJ, et al. Norepinephrine stability in saline solutions. Hosp Pharm 1988; 23: 44-59.
10. th ed. Bethesda: American Society of Health-System Pharmacists; 2005.
11. Vogelzang M, Nijboer JMM, van der Horst IC, Zijlstra F, ten Duis HJ, Nijsten MW. Hyperglycemia has a stronger relation with outcome in trauma patients than in other critically ill patients. J Trauma 2006; 60: 873-9.
12. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-67.
13. Trissel LA. Avoiding common flaws in stability and compatibility studies of injectable drugs (Editorial). Am J Hosp Pharm 1983; 40: 1159-60.
14. st ed. Bethesda: American Society of health-system pharmacists; 2006: 1344-6.
15. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003; 290: 2041-7.
16. Meisler JM, Skolaut MW. Extemporaneous sterile compounding of intravenous additives. Am J Hosp Pharm 1966; 23: 557-63.